We're a #GeneEditing company, developing novel, potentially curative therapeutics leveraging #CRISPR-based technologies. Guidelines: https://t.co/u2gHl9TmgrIntellia Therapeutics, a leading clinical-stage genome editing company, is developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.

Core values

- **Addressing Severe Diseases**: Intellia is developing potentially curative genome editing treatments for genetic diseases, cancer, and autoimmune conditions, which can profoundly improve the quality of life for patients and their families[2][3][4].
- **Patient-Centric Approach**: The company has a patient-first culture and works closely with patient organizations, indicating a strong commitment to patient needs[3][5].
- **Community Engagement**: Intellia is actively involved in community initiatives, including volunteering, fundraising, and educational programs, particularly in underserved communities[1][3][5].
- **Environmental Responsibility**: Despite a small ecological footprint, the company is taking steps to reduce its environmental impact through various sustainability initiatives[1][3][5].
- **Employee Wellbeing and Diversity**: Intellia invests in employees' professional and personal wellbeing, and has expanded its diversity, equity, and inclusion efforts[3][5].